Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Rev Sci Tech ; 24(3): 909-20, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16642761

RESUMO

Analysis of retrospective quantitative sheep pox epidemiological data from the Government Animal Husbandry Department, Karnataka, India, covering 24 years revealed significant information on sheep pox. The state has a dense sheep population including some valuable breeds. Data revealed the endemicity of the disease: there were a considerable number of outbreaks and attacks, high mortality and case fatality rates and low immunisation coverage. None of the years studied were free from infection. Temporally, the disease was most prevalent between November and May. Spatially, the disease was recorded in 19 out of 27 districts; in some of these districts sheep pox was highly endemic, in some it was endemic at low levels and in the remaining districts outbreaks occurred sporadically. Environmental factors influenced disease occurrence. Vaccine production met only one tenth of the requirement, and its peak utilisation was in the dry season.


Assuntos
Capripoxvirus , Infecções por Poxviridae/veterinária , Doenças dos Ovinos/epidemiologia , Vacinas Virais/administração & dosagem , Animais , Cruzamento , Clima , Surtos de Doenças/veterinária , Feminino , Índia/epidemiologia , Masculino , Infecções por Poxviridae/epidemiologia , Infecções por Poxviridae/mortalidade , Estudos Retrospectivos , Estações do Ano , Ovinos
2.
Trop Anim Health Prod ; 36(4): 307-20, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15241965

RESUMO

A classical live attenuated sheep pox vaccine was prepared using the Ranipet strain of sheep pox virus (SPV) at the 50th passage in a secondary lamb testicular cell system. The TCID50 and RD50 were 10(9.63)/ml and 10(9.51)/ml. respectively. The SID50 of SPV challenge virus was 10(5)/ml. The vaccine was found to have no adverse effects in laboratory animals, and was safe and effective in SPV seronegative lambs. In the field, 660 sheep were vaccinated with an immunizing dose containing 1 x 10(2) TCID50. Randomly selected vaccinated sheep mounted good cell-mediated immunity and humoral responses as measured by glucose utilization test and serum neutralization test, respectively, for the study period of 6 months.


Assuntos
Capripoxvirus/imunologia , Infecções por Poxviridae/prevenção & controle , Infecções por Poxviridae/veterinária , Doenças dos Ovinos/prevenção & controle , Doenças dos Ovinos/virologia , Vacinas Virais/imunologia , Vacinas Virais/uso terapêutico , Animais , Temperatura Corporal , Feminino , Glucose/metabolismo , Cobaias , Imunização/métodos , Imunização/veterinária , Masculino , Camundongos , Testes de Neutralização/veterinária , Infecções por Poxviridae/imunologia , Infecções por Poxviridae/virologia , Ovinos , Doenças dos Ovinos/imunologia , Vacinas Atenuadas/efeitos adversos , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/uso terapêutico , Vacinas Virais/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa